2018年7月1日
Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab
Lupus
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 27
- 号
- 8
- 開始ページ
- 1374
- 終了ページ
- 1377
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1177/0961203318760994
- 出版者・発行元
- SAGE Publications Ltd
We present a case of a woman with systemic lupus erythematosus (SLE) who had refractory episodes of neuromyelitis optica spectrum disorder (NMOSD) and was successfully treated with rituximab. She was positive for anti-aquaporin-4 (AQP4) antibody and had typical cranial and longitudinally extended spinal lesions but no optic nerve involvement. There is no established treatment for NMOSD/SLE overlap cases. Our experience suggests that rituximab may be effective for patients with combined SLE and anti-AQP4 antibody-positive NMOSD.
- ID情報
-
- DOI : 10.1177/0961203318760994
- ISSN : 1477-0962
- ISSN : 0961-2033
- ORCIDのPut Code : 42232335
- SCOPUS ID : 85048002303